53 related articles for article (PubMed ID: 35306720)
1. Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies.
Heil M
Front Immunol; 2023; 14():1259879. PubMed ID: 38439942
[TBL] [Abstract][Full Text] [Related]
2. Case Report: Gene expression profiling of COVID-19 vaccination-related lymphadenopathies reveals evidence of a dominantly extrafollicular immune response.
Menter T; Zinner CP; Berger CT; Went P; Tzankov A
Front Immunol; 2023; 14():1285168. PubMed ID: 38035070
[TBL] [Abstract][Full Text] [Related]
3. Benign fasciculation syndrome and migraine aura without headache as possible adverse events after BNT162b2 mRNA vaccination: a web-based survey.
Salai G; Ljubičić Đ; Novak R; Grgurević L
Croat Med J; 2023 Dec; 64(6):430-435. PubMed ID: 38168524
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 and guttate psoriasis: A case report and review of literature.
Ali E; Mohamed A; Abuodeh J; Albuni MK; Al-Mannai N; Salameh S; Petkar M; Habas E
Clin Case Rep; 2021 Jul; 9(7):e04568. PubMed ID: 34295501
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of sub-erythrodermic psoriasis with bimekizumab: a case report and literature review.
Licata G; Rizzo D; Frazzitta M; Zichichi L
Int J Dermatol; 2024 May; ():. PubMed ID: 38736089
[No Abstract] [Full Text] [Related]
6. Steroid use triggers severe psoriatic reaction.
Wong SR; Licata CJ; Signoff ED
Cleve Clin J Med; 2024 Mar; 91(3):147-149. PubMed ID: 38429008
[No Abstract] [Full Text] [Related]
7. New-Onset and Exacerbation of Psoriasis following COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series.
Arifin ANF; Hengky A; Widjaja M; Wijaya L
Indian J Dermatol; 2023; 68(6):724. PubMed ID: 38371588
[TBL] [Abstract][Full Text] [Related]
8. New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge.
Potestio L; Battista T; Cacciapuoti S; Ruggiero A; Martora F; Fornaro L; Camela E; Megna M
Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626687
[TBL] [Abstract][Full Text] [Related]
9. The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.
Martora F; Battista T; Ruggiero A; Scalvenzi M; Villani A; Megna M; Potestio L
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515110
[No Abstract] [Full Text] [Related]
10. Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.
Martora F; Battista T; Marasca C; Genco L; Fabbrocini G; Potestio L
Clin Cosmet Investig Dermatol; 2022; 15():2369-2382. PubMed ID: 36387962
[TBL] [Abstract][Full Text] [Related]
11. Cytokine Modulators in Plaque Psoriasis - A Review of Current and Prospective Biologic Therapeutic Approaches.
Strychalski ML; Brown HS; Bishop SC
JAAD Int; 2022 Dec; 9():82-91. PubMed ID: 36248203
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologics.
Graceffa D; Sperati F; Bonifati C; Spoletini G; Lora V; Pimpinelli F; Pontone M; Pellini R; Di Bella O; Morrone A; Cristaudo A
Front Med (Lausanne); 2022; 9():961904. PubMed ID: 36148445
[TBL] [Abstract][Full Text] [Related]
13. Erythrodermic psoriasis after COVID-19 vaccination.
Trepanowski N; Coleman EL; Melson G; Brem CE; Lam CS
JAAD Case Rep; 2022 Oct; 28():123-126. PubMed ID: 35966353
[No Abstract] [Full Text] [Related]
14. Generalized erythrodermic psoriasis triggered by vaccination against severe acute respiratory syndrome Coronavirus 2.
Tran TB; Pham NTU; Phan HN; Nguyen HT
Dermatol Ther; 2022 Jun; 35(6):e15464. PubMed ID: 35306720
[TBL] [Abstract][Full Text] [Related]
15. Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults.
Tompkins LK; Baggs J; Myers TR; Gee JM; Marquez PL; Kennedy SB; Peake D; Dua D; Hause AM; Strid P; Abara W; Rossetti R; Shimabukuro TT; Shay DK
Vaccine; 2022 Dec; 40(52):7653-7659. PubMed ID: 36372665
[TBL] [Abstract][Full Text] [Related]
16. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
Massari M; Spila Alegiani S; Morciano C; Spuri M; Marchione P; Felicetti P; Belleudi V; Poggi FR; Lazzeretti M; Ercolanoni M; Clagnan E; Bovo E; Trifirò G; Moretti U; Monaco G; Leoni O; Da Cas R; Petronzelli F; Tartaglia L; Mores N; Zanoni G; Rossi P; Samez S; Zappetti C; Marra AR; Menniti Ippolito F;
PLoS Med; 2022 Jul; 19(7):e1004056. PubMed ID: 35900992
[TBL] [Abstract][Full Text] [Related]
17. Seroconversion after anti-SARS-CoV-2 mRNA vaccinations among moderate-to-severe psoriatic patients receiving systemic biologicals-Prospective observational cohort study.
Piros ÉA; Cseprekál O; Görög A; Hidvégi B; Medvecz M; Szabó Z; Olajos F; Barabás E; Galajda N; Miheller P; Holló P
Dermatol Ther; 2022 May; 35(5):e15408. PubMed ID: 35218276
[TBL] [Abstract][Full Text] [Related]
18. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
Jarius S; Bieber N; Haas J; Wildemann B
J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
[TBL] [Abstract][Full Text] [Related]
19. Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination.
Kreuter A; Licciardi-Fernandez MJ; Burmann SN; Burkert B; Oellig F; Michalowitz AL
Clin Exp Dermatol; 2022 Jan; 47(1):161-163. PubMed ID: 34291477
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
